Numerous studies show a modification of the gut microbiota in patients with obesity or
diabetes. Animal studies have also shown a causal role of gut microbiota in liver metabolic …

Metabolic-associated fatty liver disease (MAFLD), previously called nonalcoholic fatty liver
diseases (NAFLD), is one of the most important causes of chronic liver disease worldwide …

Gut microbiota has been demonstrated to have a significant impact on the initiation,
progression and development of complications associated with multiple liver diseases …

The growing global epidemic of obesity and type 2 diabetes mellitus has de-termined an
increased prevalence of NAFLD (non-alcoholic fatty liver disease), making it the most …

Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as
nonalcoholic fatty liver disease, is becoming a significant contributor to chronic liver disease …

Abstract Background and Aims Bacterial species and microbial pathways along with
metabolites and clinical parameters may interact to contribute to non‐alcoholic fatty liver …

Résumé La maladie stéatosique du foie liée à une dysfonction métabolique (MAFLD)
touche un quart de la population mondiale, dont certains d'entre eux évolueront vers une …

A practical handbook on fecal microbiota transplantation (FMT) for physicians, nurses,
physician assistants, students, residents, and fellows, The 6 Ds of Fecal Microbiota …

With the emerging role of the gut microbiome in gastroenterology and liver disease, there
has been a substantial interest in using FMT in hepatology as a potential therapeutic …

The microbes that live in the gut, also known as the gut microbiota, play an important role in
the well-being of the host. In the last years, the development of metagenomics and …